imipenem, anhydrous has been researched along with Spondylitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, SM; Hsueh, PR; Jean, SS; Lee, YT | 1 |
Abele-Horn, M; Emmerling, P; Mann, JF | 1 |
2 other study(ies) available for imipenem, anhydrous and Spondylitis
Article | Year |
---|---|
Recurrent infections caused by cefotaxime- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis treated successfully with imipenem.
Topics: Anti-Bacterial Agents; Bacteremia; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Middle Aged; Psoas Abscess; Recurrence; Salmonella enterica; Salmonella Infections; Spondylitis; Treatment Outcome; Uremia | 2005 |
Lemierre's syndrome with spondylitis and pulmonary and gluteal abscesses associated with Mycoplasma pneumoniae pneumonia.
Topics: Abscess; Adult; Buttocks; Clindamycin; Fusobacterium Infections; Fusobacterium necrophorum; Humans; Imipenem; Lung Abscess; Male; Pneumonia, Mycoplasma; Spondylitis | 2001 |